This is a preview of subscription content, log in via an institution to check access.
References
Altland K, Winter P (1999) Potential treatment of transthyertin-type amyloidoses by sulfite. Neurogenetics 2:183–188
Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y (2004) A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 77:345–349
Berger JR, Snodgrass S, Glaser J, Post MJ, Norenberg M, Benedetto P (1989) Multifocal fibrosclerosis with hypertrophic intracranial pachymeningitis. Neurology 39:1345–1349
Bernaerts A, Vanhoenacker FM, Parizel PM, Van Goethem JW, Van Altena R, Laridon A, De Roeck J, Coeman V, De Schepper AM (2003) Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol 13:1876–1890
Brett M, Persey MR, Reilly MM, Revesz T, Booth DR, Booth SE, Hawkins PN, Pepys MB, Morgan-Hughes JA (1999) Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain 122:183–190
Collie DA, Brush JP, Lammie GA, Grant R, Kunkler I, Loenard R, Gregor A, Sellar RJ (1999) Imaging features of leptomeningeal metastases. Clin Radiol 54:765–771
Fam AG, Lavine E, Lee L, Perez-Ordonez B, Goyal M (2003) Cranial pachymeningitis: an unusual manifestation of Wegener′s granulomatosis. J Rheumatol 30:2070–2074
Fels C, Riegel A, Javaheripour-Otto K, Obenauer S (2004) Neurosarcoidosis: findings in MRI. Clin Imaging 28:166–169
Jin K, Takahashi T, Nakazaki H, Date Y, Nakazato M, Tominaga T, Itoyama Y, Ikeda S (2004) Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis. J Neurol Neurosurg Psychiatry 75:1463–1466
Kupersmith MJ, Martin V, Heller G, Shah H, Mitnick HJ (2004) Idiopathic hypertrophic pachymeningitis. Neurology 62:686–694
Nakamura M, Ando Y, Nagahara S, Sano A, Ochiya T, Maeda S, Kawaji T, Ogawa M, Hirata A, Terazaki H, Harada K, Tanihara H, Ueda H, Uchino M, Yamamura K (2004) Targeted conversion of the transthyretin gene in vitro and in vivo. Gene Ther 11:838–846
Nakamura M, Yamashita T, Ueda M, Obayashi K, Sato T, Ikeda T, Washimi Y, Hirai T, Kuwahara Y, Yamamoto MT, Uchino M, Ando Y (2005) Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis. Neurology 65:1051–1056
Palha JA, Ballinari D, Amboldi N, Cardoso I, Fernandes R, Bellotti V, Merlini G, Saraiva MJ (2000) 4′-iodo-4′-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid. Am J Pathol 156:1919–1925
Peterson SA, Klabunde T, Lashuel HA, Purkey H, Sacchettini JC, Kelly JW (1998) Inhibiting transthyretin conformational changes that lead to amyloid fibril formation. Proc Nat Acad Sci USA 95:12956–12960
Spelle L, Boulin A, Tainturier C, Visot A, Graveleau P, Pierot L (2001) Neuroimaging features of spontaneous intracranial hypotension. Neuroradiology 43:622–627
Voss NF, Davies KG, Boop FA, Montouris GD, Hermann BP (1999) Spitting automatism in complex partial seizures: a nondominant temporal localizing sign? Epilepsia 40:114–116
Author information
Authors and Affiliations
Corresponding author
Additional information
Received in revised form: 4 January 2006
Rights and permissions
About this article
Cite this article
Urban, P., Hertkorn, C., Schattenberg, J. et al. Leptomeningeal familial amyloidosis:. J Neurol 253, 1238–1240 (2006). https://doi.org/10.1007/s00415-006-0169-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-006-0169-0